EyeOnIP

Patents, Trademarks, Trade Secrets, and Copyrights Oh My!

Genentech sues for royalties on products sold after patents expired

"According to Genentech, Biogen has refused to pay royalties on any Tysabri sales since the patents expired more than four years ago...antibody drugmakers often save up 'at least several calendar quarters worth of product.'"

Reuters

2023-03-05 06:07:40

TheraTears Dry Eye Therapy - 23k+ reviews - Eye drops for dry eyes!
AD - Eicarg™ Recommended